The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $12,934.05 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of 120 count bottles of the prescription drug Xtandi 40 mg capsules. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which covers a wide range of pharmaceutical products and medical supplies for military healthcare facilities. The contract does not have a set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories. As a key supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group provides branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of the Department of Defense.
Generated 1/17/25, 9:11 AM